Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Warns Glenmark Over Temperature Excursions, Gritty Topicals

Oct 17 2019

• By Joanne S. Eglovitch

Warning Rubber Stamp — FDA Says Glenmark Still Has Not Addressed Formulation Problems • Source: Shutterstock

Related Content

Manufacturing Compliance Woes Wilt Glenmark

Nov 28 2017

US FDA Warns Indoco To Delve Further Into Manufacturing Deviation

Jul 23 2019

Aurobindo Faulted In US FDA Warning Letter For Poor Root Cause Investigations

Jul 03 2019

Manufacturing Compliance Updates In Brief From US FDA And EU

Jun 30 2018

A Warning Letter Trend Surprise: Good In India, Bad In South Korea

Oct 04 2019

US FDA Warns Lupin Again About Poor Batch Failure Investigations

Oct 03 2019

US FDA Warning Letter Hits Strides On Data Integrity

Jul 16 2019

The Quality Lowdown: Valsartan Options, Supply Chain Warnings, Button Cameras

Mar 18 2019

Related Companies

Glenmark Pharmaceuticals Limited

Additional Topics

United States Manufacturing Quality BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window